Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001661181-20-000002

President and CEO acquired 397,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gillheeney Gary S. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-02-05 Exercise or conversion : show line 1 in the form +397,900 $1.70 $676,430 397,900 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-02-05 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −397,900 $1.70 2020-02-22 397,900 0 D
Loading xslF345X03/edgar.xml…